BlackRock Investment Management’s Evoke Pharma EVOK Stock Holding History

BlackRock Investment Management’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3K	Hold	9	–	–	﹤0.01%	3832
2016 Q3	$3K	Buy	9 +4	+80%	+$1.83K	﹤0.01%	3844
2016 Q2	$5K	Buy	5 +2	+67%	+$1.57K	﹤0.01%	3847
2016 Q1	$2K	Hold	3	–	–	﹤0.01%	3971
2015 Q4	$2K	Hold	3	–	–	﹤0.01%	4010
2015 Q3	$1K	Hold	3	–	–	﹤0.01%	4117
2015 Q2	$3K	Hold	3	–	–	﹤0.01%	4034
2015 Q1	$3K	Hold	3	–	–	﹤0.01%	3935
2014 Q4	$3K	Hold	3	–	–	﹤0.01%	3995
2014 Q3	$3K	Hold	3	–	–	﹤0.01%	3971
2014 Q2	$4K	Buy	+3	New	+$3.45K	﹤0.01%	3918

Other funds holding EVOK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 24.6% 1-Year Est. Return

BlackRock Investment Management's EVOK Position: Q4 2016 in Review

BlackRock Investment Management held its Evoke Pharma (EVOK) position steady in Q4 2016 at 9 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3832.

BlackRock Investment Management first reported a position in EVOK in Q2 2014 and has held it in 11 quarters since. The position peaked at $5K in Q2 2016. 14 funds tracked by Wall St. Rank hold EVOK as of Q4 2016.

BlackRock Investment Management held 9 shares of Evoke Pharma worth $3K as of Q4 2016.
BlackRock Investment Management left its Evoke Pharma share count unchanged in Q4 2016.
Evoke Pharma made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3832 holding.
BlackRock Investment Management first reported a position in Evoke Pharma in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's Evoke Pharma position peaked at $5K in Q2 2016.
14 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.